Hun Hee Jeong Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 102 N Jack Tone Rd, Ripon, CA 95366 Phone: 209-599-1639 |
Donn Charles Sperry Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1201 W Main St, Ripon, CA 95366 Phone: 209-599-6090 |
John Le Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1201 W Main St, Ripon, CA 95366 Phone: 209-599-4686 |
Miss Gurwinder Kaur Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1201 W Main St Ste 14, Ripon, CA 95366 Phone: 209-599-4686 |
Sherry Saji George Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1201 W Main St Ste 14, Ripon, CA 95366 Phone: 209-599-4686 |
Germin Morcos Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 102 N Jack Tone Rd, Ripon, CA 95366 Phone: 209-599-1639 |
Anne Engdahl, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 102 N Jack Tone Rd, Ripon, CA 95366 Phone: 209-599-1724 Fax: 209-599-1784 |
Jennifer Vu, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 102 N Jack Tone Rd, Ripon, CA 95366 Phone: 209-599-1639 |
Harpreet Kaur Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1201 W Main St Ste 14, Ripon, CA 95366 Phone: 209-599-4686 |
News Archive
Oticon Medical has obtained 510(k) clearance from the U.S. Food and Drug Administration to market Ponto Plus, the company's newest family of bone anchored sound processors. New Ponto Plus is available in regular and power versions and is designed for use with Oticon Medical's proprietary OptiFit/OptiGrip implant design concepts that have also been cleared by the FDA for use in tissue-preserving surgery.
Boston Scientific Corporation has received CE Mark approval for use of the GUIDE DBS System, the world's first deep brain stimulation visualization system.
Payments for Medicare Advantage plans, which are operated by private health insurers, will be frozen at this year's rates in 2011, Bloomberg BusinessWeek reports.
Coeliac disease affects millions of people worldwide, but many sufferers are not aware they have the condition or may have been misdiagnosed with other illnesses. A pioneering new test developed with EU-funding should soon be available in hospitals, offering an accurate, quick, cost-effective diagnosis and monitoring solution.
› Verified 3 days ago